Key Takeaways
- Shares of AXT plunged approximately 16% following a remarkable 548% year-to-date surge
- Chief Executive Morris Young liquidated over $22 million worth of shares, triggering investor concern
- Board member Jesse Chen unloaded more than $664,000 in stock on June 4
- Current trading prices significantly exceed the analyst consensus price target of $43.80, with shares previously trading between $89 and $108
- The company’s postponed annual shareholder meeting was rescheduled and held on June 4
Shares of AXT Inc (AXTI) experienced a dramatic selloff on June 5, plummeting approximately $16.95 to close around $89.04. The single-session decline represented roughly a 16% loss in market value.
This significant retreat follows an exceptional rally that saw AXT shares soar 548% since the beginning of the year, driving prices far beyond levels that Wall Street analysts consider justified.
The primary catalyst for the selloff appears to be substantial insider transactions. Chief Executive Morris Young divested more than $22 million in company shares, a transaction that unnerved investors who had benefited from the stock’s meteoric rise.
Board Director Jesse Chen simultaneously sold 6,133 stock units on June 4 at an average transaction price of $108.28, realizing proceeds of approximately $664,081. This sale decreased his holdings by more than 6%, leaving him with 94,193 units valued at roughly $10.2 million.
Chen’s selling pattern extends beyond this single transaction. Throughout recent months, he has systematically reduced his position, selling tens of thousands of units at prices spanning from approximately $37 to $111 per share.
Analyst Targets Highlight Valuation Disconnect
The most pressing challenge facing AXT stock may be the substantial gap between its market price and analyst valuations. Wall Street’s consensus price target stands at merely $43.80, representing a fraction of the stock’s pre-decline trading levels.
Analyst opinions vary widely. Northland Securities maintains the highest target at $125.00, while B. Riley anchors the low end at $21.00 with a “neutral” stance. Wedbush recently elevated its target to $28.00 with an “outperform” rating — still dramatically below recent market prices.
The analyst community remains divided with two Buy recommendations, two Hold ratings, and one Sell designation. This fragmented outlook has failed to provide market confidence following the substantial insider share sales.
Financial Performance and Forward Outlook
AXT unveiled its latest quarterly financial results on April 30. The semiconductor materials company recorded a per-share loss of $0.01, surpassing analyst expectations of a $0.04 loss. Quarterly revenue reached $26.92 million, narrowly exceeding the Street’s $26.22 million forecast.
For the upcoming second quarter of 2026, management projects earnings between $0.06 and $0.08 per share — indicating anticipated profitability in the next reporting period.
Analysts collectively forecast full-year earnings per share of $0.20 for AXT.
The company conducted its annual shareholder meeting on June 4 following an earlier postponement caused by insufficient quorum attendance. This rescheduling contributed additional headlines during an already volatile period for the stock.
Institutional ownership accounts for approximately 49.52% of outstanding shares. Notable recent activity includes Ariose Capital Management establishing a fresh position valued at roughly $39 million during the first quarter, while Assenagon Asset Management expanded its stake by 161.9% to exceed 1.5 million units.
AXT’s 52-week trading range spans from a low of $1.72 to a peak of $143.16, with Friday’s closing price of $89.04 positioned between these boundaries.
The stock’s 50-day moving average currently sits at $88.78, while the 200-day moving average registers at $46.83.



